Substance Abuse and Mental Health Records: 2024 Final Rule 42 CFR Part 2

$149.00

SKU: 411323

Description

Learn how to maintain compliance when handling mental health and substance abuse records.
There are two key federal laws that address health records privacy HIPAA and 42 CFR Part 2. HIPAA applies to all types of health information, but 42 CFR Part 2 applies only to health information for certain substance use disorder treatment programs. The two laws have several similarities, but several key differences. This presentation will identify how HIPAA and 42 CFR Part 2 differ and overlap, and how the two regulations have evolved. The presentation will enable providers to understand how and when they are permitted to disclose substance use disorder treatment records and information in various circumstances.

Date: 2024-04-04 Start Time: 1:00 PM ET End Time: 2:05 PM ET

Learning Objectives

* You will be able to define what constitutes a Program under 42 CFR Part 2.

* You will be able to explain how to respond to a subpoena for substance use disorder records.

* You will be able to identify the differences between 42 CFR Part 2 and HIPAA.

* You will be able to recognize what is required in order to disclose substance use disorder records for treatment purposes.

History of 42 CFR Part 2
• Background
• Public Policy
• Evolution, Especially the February 2024 Updated Final Rule

Scope of 42 CFR Part 2
• What Is Included in the Scope
• To What Providers Does It Apply
• To What Records Does It Apply

Comparison of 42 CFR Part 2 to HIPAA
• Detailed Analysis of Key Provisions
• Differences
• Similarities

Disclosures Review
• To the Patient
• In Litigation
• To Other Providers

Where Is the Law Going?
• 2024 Updates to 42 CFR Part 2
• Alignment With HIPAA
• Additional Changes to 42 CFR Part 2 and HIPAA

ACHE ,CLE (Please check the Detailed Credit Information page for states that have already been approved) ,HFMA ,Additional credit may be available upon request. Contact Lorman at 866-352-9540 for further information.

Nathan A. Kottkamp-Williams Mullen